Hyperacute Stroke

Learning Target

The hyperacute stroke learning module takes a close look at the management of an ischaemic stroke within the first 24-48 hours of the onset of stroke symptoms. The learning module is divided into 11 sections, each of which contain optional links to additional webcasts and self assessment questions. If you successfully complete the final test, you will receive 3 CME points and will be able to print out your certificate.

 

 

 

Hyperacute Stroke

enter online learning

download pdf

 

 

 

 



 

 

We hope you enjoy your visit to the stroke topics chapters.


Editors

Hyperacute Stroke

 

Steve Davis

Stephen Davis, MD

Department of Neurology, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia

Stephen Davis is Professor and Director of the Division of Neurosciences and Director of Department of Neurology, at The Royal Melbourne Hospital and University of Melbourne, University of Melbourne, Parkville, Victoria, Australia.

Dr Davis’ main research interests are acute management of stroke and TIA, thrombolysis for stroke and haemorrhage after rt-PA in acute ischaemic stroke, surgery for intracerebral haemorrhage, CT screening for thrombolysis, the use of PWI and DWI measures and advances in penumbra imaging with MR, antiplatelet therapies in stroke prevention, neuroprotection and feasibiliy of neuroprotective agent administration, stroke unit design, patent foramen ovale and stroke, steroids for stroke, blood pressure reduction and ACE inhibition in secondary stroke prevention, cervicocerebral artery dissections and surgery for carotid artery stenosis.

Dr Davis is or was a principle investigator in the BRAVO (blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion) trial, the ASK (Australian Streptokinase) trial, the GAIN International (Glycine antagonist [gavestinel] in neuroprotection) trial, the PROGRESS (Perindopril pROtection aGainst REcurrent Stroke Study) trial, the ASSIST (Acute Stroke Studies Involving Selfotel Treatment) study, the ECASS II (European-Australasian Cooperative Acute Stroke Study), the MERFS (Melbourne Risk Factor Study), the ASAP (Avoid Stroke as Soon as Possible) general practice stroke audit, and the ICH NovoSeven® trial.

Dr Davis is or has been a member of the Australian Association of Neurologists (AAN), the International Society of Hypertension (ISH), the Stroke Society of Australasia, and the International Trial Subcommittee of the International Stroke Liaison Committee, American Stroke Association. He was Chairman of the 4th World Stroke Conference in Melbourne 2000 and Chairman of the Education Committee, World Congress of Neurology, Sydney 2005.

Dr Davis has authored and co-authored more than 200 scientific papers on cerebrovascular diseases in journals such as Stroke, Lancet Neurology, Cerebrovascular Diseases, Circulation, the Journal of Hypertension, Lancet, Neurology, Current Opinion in Neurology, the American Journal of Neuroradiology, and Annals of Neurology.

   Peter Schellinger

Peter D. Schellinger, MD, PhD

Stroke Unit, Department of Neurology, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany

Peter D. Schellinger is Professor of Neurology and Senior Physician at the Stroke Unit, Department of Neurology at the Friedrich-Alexander-University, Erlangen-Nuremberg, Germany.

Dr Schellinger’s special interests are acute therapy, prevention and prophylaxis of ischaemic stroke and thrombolysis. In the last years Dr Schellinger had become one of the leading experts for diagnostics in stroke especially in the role of stroke MRI in ischaemic stroke and intracranial haemorrhage including subarachnoid haemorrhage as well as trial design.

Before going to Erlangen-Nuremberg he was Senior Physician at the Department of Neurology, Ruprecht-Karls-University in Heidelberg, Germany. Dr Schellinger is or has been an investigator in the MRI in Acute Stroke Study Group of the German Competence Network Stroke, in the UCLA Thrombolysis Group, and in the European Consensus Group. He was awarded for his research in evidence-based medicine with the Adolf-Wallenberg Award in 2002.

Dr Schellinger has authored and co-authored more than 70 excellent publications on cerebrovascular diseases in peer-reviewed journals such as Stroke, the American Journal of Neuroradiology, Neuroradiology, the Annals of Neurology, Lancet Neurology, Spine, Cerebrovascular Diseases, Critical Care Medicine, and Neurology. Together with his colleague Dr Fiebach he authored the book ‘Stroke MRI’ in 2003.

 


© World Stroke Academy. All rights reserved.